AzTrials
AzTrials

MicrobiomeNCT04611945

Westlake Sailing Cohort

An observational study of Microbiome and Glucose Metabolism, run by Westlake University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Little is known about the dynamic change of human microbiome in different body sites including skin, mouth and gut during sailing. The present study aims to reveal the change of human microbiome in response to the sailing environment in a 1-month period, and its implication for human health. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Microbiome, Glucose Metabolism, Mood
How many people
17 participants
Where
1 siteChina
Study dates
10 Nov 2020to 26 Apr 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Individuals who will sail by Shenkuo, a scientific research ship, December 2020.

Who may be able to join

  • Willingness and capability to complete the study protocol

Who cannot join

  • Inability or unwillingness to approved to provide informed consent.
  • Women who are pregnant or lactating.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Westlake University

    Hangzhou, Zhejiang, 310024

Other trials in China

About this study

Official title: Westlake Sailing Cohort: Dynamic Change of Human Microbiome During Sailing

Little is known about the dynamic change of human microbiome in different body sites including skin, mouth and gut during sailing. The present study aims to reveal the change of human microbiome in response to the sailing environment in a 1-month period, and its implication for human health.

Read the detailed description

This study will recruit a number of participants who are going to sail for mariana trench from Shenzhen, China. Characteristics of the participants will be described by a series of index of stool, urine, skin microbiota and tongue coating. All the biospecimen will be collected before and during the voyage. Stool at the 2nd, the 4th and the 12th week after the voyage and blood sample at the baseline will also be collected. Participants' mood states, health-related quality of life, fatigue score and sleep quality will be investigated with questionnaires throughout the 1-month period. Participants are asked to record diseases and symptoms, if any, when sailing. All the data will be used to analyse how microbiota change and be involved in human health during a voyage.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gut microbial abundant change

    Gut microbial communities and their abundant features will be analysed based on shotgun metagenomic sequencing.

    Measured: Day 1, day 10, day 16, day 23, day 28

  2. Tongue coating microbial abundant change

    Tongue coating microbial communities and their abundant features will be analysed based on shotgun metagenomic sequencing.

    Measured: Day 1, day 10, day 16, day 23, day 28

Secondary outcomes (8)
  1. Mood states change over 4 weeks

    Transient, fluctuating feelings, and enduring affect states will be assessed by the Profile of Mood States-Short Form (POMS-SF) . POMS-SF contains 30 questions that assess the following seven different moods: anger-hostility (AH), confusion-bewilderment (CB), depression-dejection (DD), fatigue-inertia (FI), tension-anxiety (TA), vigoractivity (VA), and friendliness (F). Total mood disturbance (TMD) scores were calculated based on the previous seven factors. High scores for VA and F indicate a positive mood state, while high scores for AH, CB, DD, FI, TA, and TMD indicate a negative mood state.

    Measured: Day 1, day 10, day 16, day 23, day 30

  2. Health-related quality of life change over the one-month sailing

    Health-related quality of life will be assessed by the Short-Form 36 Health Status Questionnaire(SF-36). It contains eight subscales scoring from 0 to 100 points for each, with higher scores indicating better quality of life.

    Measured: Day 1, day 30

  3. Sleep quality change over the one-month sailing

    The Pittsburgh Sleep Quality Index (PSQI)will be used to assess sleep quality. It comprises 19 items for self-reported sleep quality in the last month and five additional questions to be answered by roommates, if applicable. The 19 items are grouped into seven component scores: sleep quality, sleep latency, sleep duration, efficiency of habitual sleep, sleep disturbance, use of sleep medication, and diurnal dysfunction. These are then added to a global PSQI score. The PSQI score ranges from 0 to 21, with a higher score indicative of poorer sleep quality.

    Measured: Day 1, day 30

  4. Short-chain fatty acids change

    Short-chain fatty acids will be analysed by performing liquid chromatography/quadrupole time-of-flight mass spectrometry (LC/Q-TOF/MS).

    Measured: Day 1, day 10, day 16, day 23, day 28

  5. Weight change

    Weight will be described by kilogram.

    Measured: Day 1, day 10, day 16, day 23, day 28

  6. Blood pressure change

    Systolic pressure and diastolic pressure will be measured and described by mmHg.

    Measured: Day 1, day 10, day 16, day 23, day 28

  7. Fatigue score change

    The Multi-dimensional Fatigue Inventory (MFI-20) will be used to measure aspects of fatigue experienced during the previous days. It consists of five subscales of fatigue: general fatigue (GF), physical fatigue (PF), re-duced motivation (RM), reduced activity (RA), and mental fatigue (MF). The score ranges from 20 to 100. Higher scores indicate a higher degree of fatigue.

    Measured: Day 1, day 10, day 16, day 23, day 30

  8. Skin microbial abundant change

    Skin microbial communities and their abundant features will be analysed based on shotgun metagenomic sequencing.

    Measured: Day 1, day 10, day 16, day 23, day 28

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Nov 2020
  2. Study start10 Nov 2020
  3. Primary completion31 Jan 2022
  4. Study completion26 Apr 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
17 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04611945
Sponsor's protocol ID
20200911ZJS001
Status last verified
Apr 2022
First submitted
9 Oct 2020
Last updated
28 Apr 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Microbiome and Glucose Metabolism, run by Westlake University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gut microbial abundant change (time frame: Day 1, day 10, day 16, day 23, day 28). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2022; AzTrials last refreshed its copy on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in